67 related articles for article (PubMed ID: 7975926)
1. [The receptor binding study in vivo].
Inoue O; Kobayashi K
Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Aug; 14(4):215-25. PubMed ID: 7975926
[TBL] [Abstract][Full Text] [Related]
2. Brain radioligands--state of the art and new trends.
Halldin C; Gulyás B; Langer O; Farde L
Q J Nucl Med; 2001 Jun; 45(2):139-52. PubMed ID: 11476163
[TBL] [Abstract][Full Text] [Related]
3. [Neurotransmitter-receptor-imaging].
Cordes M; Hierholzer J; Nikolai-Beyer K
Radiologe; 1993 Nov; 33(11):612-9. PubMed ID: 7904078
[TBL] [Abstract][Full Text] [Related]
4. Concerning strategies for in vivo measurement of receptor binding using positron emission tomography.
Zeeberg BR; Brice AN; Wagner HN
J Cereb Blood Flow Metab; 1987 Apr; 7(2):252-5. PubMed ID: 3494030
[No Abstract] [Full Text] [Related]
5. Kinetic analysis.
Blomqvist G
Wien Klin Wochenschr; 1991; 103(15):451-7. PubMed ID: 1926871
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic considerations in the PET and SPECT evaluation of CNS receptors.
Mazière B; Delforge J
Q J Nucl Med; 1997 Jun; 41(2):119-26. PubMed ID: 9203851
[TBL] [Abstract][Full Text] [Related]
7. Applications of neuroreceptor imaging to psychiatry research.
Smith GS; Koppel J; Goldberg S
Psychopharmacol Bull; 2003; 37(4):26-65. PubMed ID: 15131516
[TBL] [Abstract][Full Text] [Related]
8. Vulnerability of positron emission tomography radiotracers to endogenous competition. New insights.
Laruelle M; Huang Y
Q J Nucl Med; 2001 Jun; 45(2):124-38. PubMed ID: 11476162
[TBL] [Abstract][Full Text] [Related]
9. A radioiodinated 7alpha-O-iodoallyl diprenorphine for mapping opioid receptors.
Wang RF; Tafani JA; Zajac JM; Guiraud R
Neuropeptides; 1999 Dec; 33(6):498-502. PubMed ID: 10657531
[TBL] [Abstract][Full Text] [Related]
10. Ab initio computational study of positron emission tomography ligands interacting with lipid molecule for the prediction of nonspecific binding.
Rosso L; Gee AD; Gould IR
J Comput Chem; 2008 Nov; 29(14):2397-405. PubMed ID: 18442082
[TBL] [Abstract][Full Text] [Related]
11. [Strategy for development of imaging biomarkers].
Ishiwata K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Apr; 29(2):67-71. PubMed ID: 19562944
[TBL] [Abstract][Full Text] [Related]
12. Quantitative in vitro phosphor imaging using [3H] and [18F] radioligands: the effects of chronic desipramine treatment on serotonin 5-HT2 receptors.
Strome EM; Jivan S; Doudet DJ
J Neurosci Methods; 2005 Jan; 141(1):143-54. PubMed ID: 15585298
[TBL] [Abstract][Full Text] [Related]
13. Lithiation of functionalized fluoroquinolines: synthesis of dihalo-2-phenylquinoline-4-carboxamides and in vitro evaluation as NK-3 receptor ligands for medical imaging studies.
Bennacef I; Tymciu S; Dhilly M; Mongin F; Quéguiner G; Lasne MC; Barré L; Perrio C
J Org Chem; 2004 Apr; 69(7):2622-5. PubMed ID: 15049675
[TBL] [Abstract][Full Text] [Related]
14. An introduction to PET and SPECT neuroreceptor quantification models.
Ichise M; Meyer JH; Yonekura Y
J Nucl Med; 2001 May; 42(5):755-63. PubMed ID: 11337572
[TBL] [Abstract][Full Text] [Related]
15. [2-11C]isopropyl-, [1-11C]ethyl-, and [11C]methyl-labeled phenoxyphenyl acetamide derivatives as positron emission tomography ligands for the peripheral benzodiazepine receptor: radiosynthesis, uptake, and in vivo binding in brain.
Zhang MR; Ogawa M; Maeda J; Ito T; Noguchi J; Kumata K; Okauchi T; Suhara T; Suzuki K
J Med Chem; 2006 May; 49(9):2735-42. PubMed ID: 16640334
[TBL] [Abstract][Full Text] [Related]
16. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
[TBL] [Abstract][Full Text] [Related]
17. [SPECT and PET in neurobiology].
Paulson OB; Lassen NA
Nord Med; 1997 Dec; 112(10):356-60. PubMed ID: 9441274
[TBL] [Abstract][Full Text] [Related]
18. PET-based neuropharmacology: state of the art.
Lucignani G; Moresco RM; Fazio F
Cerebrovasc Brain Metab Rev; 1989; 1(4):271-87. PubMed ID: 2701655
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro studies of the dopaminergic system in movement disorders.
Playford ED; Brooks DJ
Cerebrovasc Brain Metab Rev; 1992; 4(2):144-71. PubMed ID: 1627440
[TBL] [Abstract][Full Text] [Related]
20. A statistical method for the analysis of positron emission tomography neuroreceptor ligand data.
Aston JA; Gunn RN; Worsley KJ; Ma Y; Evans AC; Dagher A
Neuroimage; 2000 Sep; 12(3):245-56. PubMed ID: 10944407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
